Latest News

Expert Insights Highlight Novel ITK Inhibition With Soquelitinib for AD
Expert Insights Highlight Novel ITK Inhibition With Soquelitinib for AD

May 19th 2025

Albert Chiou, MD, MBA, discusses early clinical data on soquelitinib for atopic dermatitis, highlighting its targeted ITK inhibition, dose-dependent efficacy, favorable safety profile, and more.

No Link Found Between JAK Inhibitor Use and Unprovoked Venous Thromboembolisms in Adults with Atopic Dermatitis
No Link Found Between JAK Inhibitor Use and Unprovoked Venous Thromboembolisms in Adults with Atopic Dermatitis

May 19th 2025

GLP-1 Therapy Offers Dual Benefits for Skin and Heart
GLP-1 Therapy Offers Dual Benefits for Skin and Heart

May 16th 2025

Prolonged Use of Oral Corticosteroids in Atopic Dermatitis Linked to Increased Cardiovascular Risks
Prolonged Use of Oral Corticosteroids in Atopic Dermatitis Linked to Increased Cardiovascular Risks

May 14th 2025

Dual Inhibitor TRIV-509 Shows Promise for Rapid Improvement in Atopic Dermatitis
Dual Inhibitor TRIV-509 Shows Promise for Rapid Improvement in Atopic Dermatitis

May 13th 2025

Latest CME Events & Activities

Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis

View More

Revolutionizing Atopic Dermatitis (RAD) Conference 2025

June 6-7, 2025

Register Now!

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

July 26, 2025

Register Now!

Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color

View More

Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach

View More

Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis

View More

Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis

View More

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

View More

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

View More

Dermalorian™ Webinar: Shedding Light on Patient-Reported Outcomes to Assess Disease Severity in Patients With Atopic Dermatitis

View More

Where Do Biologics Fit Into the Management of Moderate-to-Severe Atopic Dermatitis?

View More

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

View More

Burst CME: Targeted Therapy for Optimal Psoriasis Management

View More

© 2025 MJH Life Sciences

All rights reserved.